相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Menin is necessary for long term maintenance of meningioma-1 driven leukemia
Clara Libbrecht et al.
LEUKEMIA (2021)
Menin inhibitor MI-3454 induces remission in MLL1-rearranged and NPM1-mutated models of leukemia
Szymon Klossowski et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
WDR5 is a conserved regulator of protein synthesis gene expression
Audra F. Bryan et al.
NUCLEIC ACIDS RESEARCH (2020)
Displacement of WDR5 from Chromatin by a WIN Site Inhibitor with Picomolar Affinity
Erin R. Aho et al.
CELL REPORTS (2019)
Interaction with XPO1 is essential for SETBP1 to induce myeloid transformation
Nhu Nguyen et al.
LEUKEMIA (2019)
Interaction of the oncoprotein transcription factor MYC with its chromatin cofactor WDR5 is essential for tumor maintenance
Lance R. Thomas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia
Andrei V. Krivtsov et al.
CANCER CELL (2019)
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub
Rocco Piazza et al.
NATURE COMMUNICATIONS (2018)
Ribosome biogenesis in cancer: new players and therapeutic avenues
Joffrey Pelletier et al.
NATURE REVIEWS CANCER (2018)
CIP2A- and SETBP1-mediated PP2A inhibition reveals AKT S473 phosphorylation to be a new biomarker in AML
Claire M. Lucas et al.
BLOOD ADVANCES (2018)
MLL2, Not MLL1, Plays a Major Role in Sustaining MLL-Rearranged Acute Myeloid Leukemia
Yufei Chen et al.
CANCER CELL (2017)
Runx1 repression by histone deacetylation is critical for Setbp1-induced mouse myeloid leukemia development
B. A. Vishwakarma et al.
LEUKEMIA (2016)
NUP98 Fusion Proteins Interact with the NSL and MLL1 Complexes to Drive Leukemogenesis
Haiming Xu et al.
CANCER CELL (2016)
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia
Michael W. M. Kuhn et al.
CANCER DISCOVERY (2016)
Myb expression is critical for myeloid leukemia development induced by Setbp1 activation
Nhu Nguyen et al.
ONCOTARGET (2016)
Leukemogenic MLL-ENL Fusions Induce Alternative Chromatin States to Drive a Functionally Dichotomous Group of Target Genes
Maria-Paz Garcia-Cuellar et al.
CELL REPORTS (2016)
New frontiers in translational control of the cancer genome
Morgan L. Truitt et al.
NATURE REVIEWS CANCER (2016)
Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth
Jiajun Zhu et al.
NATURE (2015)
Pharmacological targeting of the Wdr5-MLL interaction in C/EBP alpha N-terminal leukemia
Florian Grebien et al.
NATURE CHEMICAL BIOLOGY (2015)
LMO2 (LIM domain only 2) is expressed in a subset of acute myeloid leukaemia and correlates with normal karyotype
Jay L. Patel et al.
HISTOPATHOLOGY (2014)
The SUMO-Specific Isopeptidase SENP3 Regulates MLL1/MLL2 Methyltransferase Complexes and Controls Osteogenic Differentiation
Arnab Nayak et al.
MOLECULAR CELL (2014)
The Histone Methyltransferase Activity of MLL1 Is Dispensable for Hematopoiesis and Leukemogenesis
Bibhu P. Mishra et al.
CELL REPORTS (2014)
Epigenetic Roles of MLL Oncoproteins Are Dependent on NF-κB
Hsu-Ping Kuo et al.
CANCER CELL (2013)
SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias
F. Damm et al.
LEUKEMIA (2013)
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia
Rocco Piazza et al.
NATURE GENETICS (2013)
Somatic SETBP1 mutations in myeloid malignancies
Hideki Makishima et al.
NATURE GENETICS (2013)
Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia
Hirotoshi Sakaguchi et al.
NATURE GENETICS (2013)
EVI1 is critical for the pathogenesis of a subset of MLL-AF9-rearranged AMLs
Eric M. J. Bindels et al.
BLOOD (2012)
Setbp1 promotes the self-renewal of murine myeloid progenitors via activation of Hoxa9 and Hoxa10
Kevin Oakley et al.
BLOOD (2012)
MLL fusion proteins preferentially regulate a subset of wild-type MLL target genes in the leukemic genome
Qian-fei Wang et al.
BLOOD (2011)
Role for Dpy-30 in ES Cell-Fate Specification by Regulation of H3K4 Methylation within Bivalent Domains
Hao Jiang et al.
CELL (2011)
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Johannes Zuber et al.
NATURE (2011)
SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia
Ion Cristobal et al.
BLOOD (2010)
Leukemogenic transformation by HOXA cluster genes
Christian Bach et al.
BLOOD (2010)
Association of a Leukemic Stem Cell Gene Expression Signature With Clinical Outcomes in Acute Myeloid Leukemia
Andrew J. Gentles et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
An Ash2L/RbBP5 Heterodimer Stimulates the MLL1 Methyltransferase Activity through Coordinated Substrate Interactions with the MLL1 SET Domain
Fang Cao et al.
PLOS ONE (2010)
On the Mechanism of Multiple Lysine Methylation by the Human Mixed Lineage Leukemia Protein-1 (MLL1) Core Complex
Anamika Patel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Menin critically links MLL proteins with LEDGE on cancer-associated target genes
Akihiko Yokoyama et al.
CANCER CELL (2008)
Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency
Maria Barna et al.
NATURE (2008)
Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential
Piu Wong et al.
GENES & DEVELOPMENT (2007)
MII has a critical role in fetal and adult hematopoietic stem cell self-renewal
Kathryn A. McMahon et al.
CELL STEM CELL (2007)
Unique and independent roles for MLL in adult hematopoietic stem cells and progenitors
Craig D. Jude et al.
CELL STEM CELL (2007)
Chromatin modifications and their function
Tony Kouzarides
CELL (2007)
Molecular regulation of H3K4 trimethylation by ASH2L, a shared subunit of MLL complexes
Melissa M. Steward et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)
Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9
Andrei V. Krivtsov et al.
NATURE (2006)
Histone H3 recognition and presentation by the WDR5 module of the MLL1 complex
Alexander J. Ruthenburg et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)
Regulation of MLL1 H3K4 methyltransferase activity by its core components
Yali Dou et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)
Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1
MG Ott et al.
NATURE MEDICINE (2006)
Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression
A Yokoyama et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors
BJP Huntly et al.
CANCER CELL (2004)
Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors
A Cozzio et al.
GENES & DEVELOPMENT (2003)
Taspase1:: A threonine aspartase required for cleavage of MLL and proper HOX gene expression
JJD Hsieh et al.
CELL (2003)
Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells
J Lessard et al.
NATURE (2003)
Leukemia proto-oncoprotein MLL is proteolytically processed into 2 fragments with opposite transcriptional properties
A Yokoyama et al.
BLOOD (2002)
ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation
T Nakamura et al.
MOLECULAR CELL (2002)
MLL targets SET domain methyltransferase activity to Hox gene promoters
TA Milne et al.
MOLECULAR CELL (2002)
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia
SA Armstrong et al.
NATURE GENETICS (2002)
Identification and characterization of SEB, a novel protein that binds to the acute undifferentiated leukemia-associated protein SET
M Minakuchi et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
The genetic program of hematopoietic stem cells
RL Phillips et al.
SCIENCE (2000)